XTX Topco Ltd Makes New Investment in Revvity, Inc. (NYSE:RVTY)

XTX Topco Ltd acquired a new stake in Revvity, Inc. (NYSE:RVTY) during the 2nd quarter, Holdings Channel reports. The institutional investor acquired 12,894 shares of the company’s stock, valued at approximately $1,352,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Czech National Bank grew its holdings in shares of Revvity by 0.5% in the first quarter. Czech National Bank now owns 21,713 shares of the company’s stock worth $2,280,000 after purchasing an additional 99 shares during the last quarter. Garrison Asset Management LLC raised its stake in shares of Revvity by 0.5% during the second quarter. Garrison Asset Management LLC now owns 21,328 shares of the company’s stock valued at $2,236,000 after acquiring an additional 103 shares in the last quarter. TriaGen Wealth Management LLC boosted its holdings in shares of Revvity by 2.3% in the second quarter. TriaGen Wealth Management LLC now owns 4,767 shares of the company’s stock valued at $500,000 after purchasing an additional 107 shares during the period. Guinness Asset Management LTD grew its stake in Revvity by 3.3% in the second quarter. Guinness Asset Management LTD now owns 3,587 shares of the company’s stock worth $376,000 after purchasing an additional 116 shares in the last quarter. Finally, Inspire Investing LLC increased its holdings in Revvity by 2.9% during the 1st quarter. Inspire Investing LLC now owns 4,190 shares of the company’s stock worth $440,000 after purchasing an additional 117 shares during the period. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. JPMorgan Chase & Co. increased their price target on Revvity from $105.00 to $120.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 30th. Barclays increased their target price on shares of Revvity from $115.00 to $125.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 30th. TD Cowen boosted their price target on shares of Revvity from $130.00 to $141.00 and gave the company a “buy” rating in a report on Tuesday, July 30th. Leerink Partners assumed coverage on shares of Revvity in a research note on Monday, July 8th. They set an “outperform” rating and a $125.00 price objective on the stock. Finally, Wells Fargo & Company assumed coverage on shares of Revvity in a research note on Tuesday, August 27th. They issued an “equal weight” rating and a $130.00 price objective for the company. Eight equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $126.00.

Insider Buying and Selling

In other news, insider Joel S. Goldberg sold 3,500 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total value of $412,510.00. Following the transaction, the insider now directly owns 33,400 shares of the company’s stock, valued at $3,936,524. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.60% of the stock is currently owned by company insiders.

Revvity Price Performance

Shares of NYSE RVTY opened at $122.89 on Friday. Revvity, Inc. has a fifty-two week low of $79.50 and a fifty-two week high of $128.15. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.98 and a current ratio of 2.27. The company has a market cap of $15.16 billion, a PE ratio of 101.56, a P/E/G ratio of 2.87 and a beta of 1.05. The business has a 50-day simple moving average of $119.06 and a two-hundred day simple moving average of $110.57.

Revvity (NYSE:RVTY) last released its earnings results on Monday, July 29th. The company reported $1.22 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.10. Revvity had a net margin of 6.26% and a return on equity of 7.34%. The company had revenue of $691.70 million for the quarter, compared to the consensus estimate of $690.33 million. Revvity’s revenue was down 2.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.21 EPS. As a group, equities analysts expect that Revvity, Inc. will post 4.75 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Investors of record on Friday, October 18th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.23%. The ex-dividend date is Friday, October 18th. Revvity’s payout ratio is 23.14%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.